Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/S1473-3099(20)30483-7 http://scihub22266oqcxt.onion/10.1016/S1473-3099(20)30483-7 32539990!7292605!32539990     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Lancet+Infect+Dis 2020 ; 20 (8): e192-e197 Nephropedia Template TP {{tp|p=32539990|t=2020. A minimal common outcome measure set for COVID-19 clinical research |pdf=|usr=}}{{32539990}} gab.com Text A minimal common outcome measure set for COVID-19 clinical research JO: Lancet Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32539990 #FOAvip Clinical research is necessary for an effective response to an emerging infectious disease outbreak. However, research efforts are often hastily organised and done using various research tools, with the result that pooling data across studies is challenging. In response to the needs of the rapidly evolving COVID-19 outbreak, the Clinical Characterisation and Management Working Group of the WHO Research and Development Blueprint programme, the International Forum for Acute Care Trialists, and the International Severe Acute Respiratory and Emerging Infections Consortium have developed a minimum set of common outcome measures for studies of COVID-19. This set includes three elements: a measure of viral burden (quantitative PCR or cycle threshold), a measure of patient survival (mortality at hospital discharge or at 60 days), and a measure of patient progression through the health-care system by use of the WHO Clinical Progression Scale, which reflects patient trajectory and resource use over the course of clinical illness. We urge investigators to include these key data elements in ongoing and future studies to expedite the pooling of data during this immediate threat, and to hone a tool for future needs. Twit Text FOAVip A minimal common outcome measure set for COVID-19 clinical research ????Lancet Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32539990 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32539990 #FOAvip English Wikipedia <ref>{{Cite pmid|32539990}}</ref> A minimal common outcome measure set for COVID-19 clinical research #MMPMID32539990 ä Lancet Infect Dis 2020[Aug]; 20 (8): e192-e197 PMID32539990show ga Clinical research is necessary for an effective response to an emerging infectious disease outbreak. However, research efforts are often hastily organised and done using various research tools, with the result that pooling data across studies is challenging. In response to the needs of the rapidly evolving COVID-19 outbreak, the Clinical Characterisation and Management Working Group of the WHO Research and Development Blueprint programme, the International Forum for Acute Care Trialists, and the International Severe Acute Respiratory and Emerging Infections Consortium have developed a minimum set of common outcome measures for studies of COVID-19. This set includes three elements: a measure of viral burden (quantitative PCR or cycle threshold), a measure of patient survival (mortality at hospital discharge or at 60 days), and a measure of patient progression through the health-care system by use of the WHO Clinical Progression Scale, which reflects patient trajectory and resource use over the course of clinical illness. We urge investigators to include these key data elements in ongoing and future studies to expedite the pooling of data during this immediate threat, and to hone a tool for future needs. |*Patient Outcome Assessment[MESH] |*Treatment Outcome[MESH] |Betacoronavirus/*isolation & purification[MESH] |COVID-19[MESH] |Clinical Trials as Topic/*standards[MESH] |Coronavirus Infections/*therapy[MESH] |Humans[MESH] |Outcome Assessment, Health Care/*standards[MESH] |Pandemics[MESH] |Pneumonia, Viral/*therapy[MESH] |SARS-CoV-2[MESH] |Survival Analysis[MESH]A minimal common outcome measure set for COVID-19 clinical research (epmc).pdf DeepDyve Pubget Overpricing